US-based medical manufacturer BioLab has announced a strategic investment and partnership with German wound diagnostics firm cureVision.
cureVision is a health technology firm focused on enhancing wound care, which leverages artificial intelligence (AI) and advanced sensor technology.
The partnership aims to transform wound care in the US using cureVision’s technology, certified under the European Union Medical Device Regulation (EU MDR).
The technology is said to enable clinicians to perform quick, contactless assessments, providing detailed insights in under two minutes.
Also, it simplifies wound measurement, analysis, and documentation, aiding healthcare professionals in tracking healing progress and reducing manual tasks.
cureVision CEO Richard Fobo said: “cureVision is putting advanced technologies to work so providers can focus on what matters most: the patient.
“We are excited to showcase our technology via BioLab’s outstanding network and presence in the US.”
The collaboration is expected to help cureVision navigate the US regulatory and reimbursement pathways, supported by BioLab’s extensive distribution network.
Also, cureVision would benefit from the US market insights and guidance from BioLab’s medical advisory team.
The collaboration aims to deliver comprehensive wound care solutions, benefiting patients, providers, and payers, said BioLab.
BioLab chief science officer Carlos Encinas said: “We see immense potential in cureVision’s AI-driven technologies to transform wound care workflows.
“By combining their advanced imaging capabilities with our clinical expertise and distribution network, we’re accelerating a smarter, more efficient future for wound management.”
Based in Phoenix, Arizona, BioLab is focused on developing wound healing products using human tissue allografts from amniotic membranes.
In March this year, BioLab announced a partnership with Germany-based biotechnology firm Real Collagen to develop new wound care products using fish collagen. Real Collagen is engaged in developing and producing raw hydrogel material containing fish collagen.
